As of 6 Nov 2026, Onyx Biotec trades at ₹34.60. It is listed on NSE, and we do not yet have reported financials to work out valuation ratios for it.
past year
- ₹36.35
- ₹36.75
- ₹34.60
- ₹35.00
- 12K
Health check
- Returnsn/a
Less than a year of price history.
- Price tagn/a
P/E isn’t reported.
- Growthn/a
Not enough yearly results to measure.
- Profitabilityn/a
Return ratios aren’t reported.
- Balance sheetn/a
Balance sheet figures aren’t reported.
- Red flags1 to check
Promoter stake down from 65.1% to 41.7%.
Key metrics
- Market cap
- n/a
- P/E
- n/a
- Price to book
- n/a
- Dividend yield
- n/a
- ROE
- n/a
- Return on equity
- ROCE
- n/a
- Return on capital employed
- Debt to equity
- n/a
- EPS (TTM)
- n/a
- Face value ₹10
- OPM (TTM)
- n/a
- Sales growth
- n/a
- Year-ago quarter not reported
- Profit growth
- n/a
- Year-ago quarter not reported
- Price to sales
- n/a
Strengths and risks
Risks to check
- Promoter stake down from 65.1% to 41.7%.
About Onyx Biotec
No company description is available.
- ISIN
- INE0WVU01018
Price range
₹34.60₹36.75
₹34.60₹36.75
- Avg volume (3M)
- –
- 1-year return
- –
- From 52-week high
- minus 5.9%
Peers
We couldn’t find listed peers for this company.
Quarterly results
This company doesn’t report these figures in a format we can read yet.
Profit & loss
This company doesn’t report these figures in a format we can read yet.
Forecast
Balance sheet
This company doesn’t report these figures in a format we can read yet.
Cash flow
This company doesn’t report these figures in a format we can read yet.
Shareholding pattern
41.7%
- Promoters41.74%
- Public58.26%
| Quarter | Split | Promoters | Public | Promoter change |
|---|---|---|---|---|
| 30 Sep 2026 | 41.74% | 58.26% | minus 23.36 | |
| 31 Mar 2026 | 65.10% | 34.90% | 0.00 | |
| 30 Sep 2025 | 65.10% | 34.90% | 0.00 | |
| 31 Mar 2025 | 65.10% | 34.90% | 0.00 | |
| 20 Nov 2024 | 65.10% | 34.90% | – |
Major shareholders
Filings & events
News
No recent news coverage found.